Hefter - JoVE Visualize

Showing results (141-150 of 317) with videos related to

Pageof 32

Sort By:

BMJ Open|August 7, 2012

Prospective analysis of neutralising antibody titres in secondary non-responders under continuous treatment with a botulinumtoxin type A preparation free of complexing proteins--a single cohort 4-year follow-up studyHarald Hefter, Christian Hartmann, Ulrike Kahlen, et al.

Pain Medicine (Malden, Mass.)|June 23, 2011

Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?Reiner Benecke, Axel Heinze, Gerhard Reichel, et al.

Journal of Computer Assisted Tomography|July 1, 1995

MRI of the brain in Wilson disease: T2 signal loss under therapyV Engelbrecht, G Schlaug, H Hefter, et al.

Toxins|August 6, 2021

Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot DropHarald Hefter, Werner Nickels, Dietmar Rosenthal, et al.

Brain and Language|October 1, 1992

Impairment of temporal organization of speech in basal ganglia diseasesJ Volkmann, H Hefter, H W Lange, et al.

Cancer Research|January 1, 1978

Impairment of Na+-dependent amino acid transport in a cultured human T-cell line by hyperthermia and irradiationL Kwock, P S Lin, K Hefter, et al.

Medicina (Kaunas, Lithuania)|January 21, 2022

The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot StudyHarald Hefter, Isabelle Schomaecker, Max Schomaecker, et al.

Wiener Klinische Wochenschrift|October 28, 2004

[Treatment of the spastic drop foot with botulinum toxin type A in adult patients]B Voller, D Földy, H Hefter, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1990

Disturbances in human arm movement trajectory due to mild cerebellar dysfunctionS H Brown, H Hefter, M Mertens, et al.

Pain|June 6, 2006

Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre studyHartmut Göbel, Axel Heinze, Gerhard Reichel, et al.

Pageof 32

Showing results (141-150 of 317) with videos related to

Sort By:

Pageof 32

BMJ Open|August 7, 2012

Prospective analysis of neutralising antibody titres in secondary non-responders under continuous treatment with a botulinumtoxin type A preparation free of complexing proteins--a single cohort 4-year follow-up studyHarald Hefter, Christian Hartmann, Ulrike Kahlen, et al.

Pain Medicine (Malden, Mass.)|June 23, 2011

Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?Reiner Benecke, Axel Heinze, Gerhard Reichel, et al.

Journal of Computer Assisted Tomography|July 1, 1995

MRI of the brain in Wilson disease: T2 signal loss under therapyV Engelbrecht, G Schlaug, H Hefter, et al.

Toxins|August 6, 2021

Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot DropHarald Hefter, Werner Nickels, Dietmar Rosenthal, et al.

Brain and Language|October 1, 1992

Impairment of temporal organization of speech in basal ganglia diseasesJ Volkmann, H Hefter, H W Lange, et al.

Cancer Research|January 1, 1978

Impairment of Na+-dependent amino acid transport in a cultured human T-cell line by hyperthermia and irradiationL Kwock, P S Lin, K Hefter, et al.

Medicina (Kaunas, Lithuania)|January 21, 2022

The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot StudyHarald Hefter, Isabelle Schomaecker, Max Schomaecker, et al.

Wiener Klinische Wochenschrift|October 28, 2004

[Treatment of the spastic drop foot with botulinum toxin type A in adult patients]B Voller, D Földy, H Hefter, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1990

Disturbances in human arm movement trajectory due to mild cerebellar dysfunctionS H Brown, H Hefter, M Mertens, et al.

Pain|June 6, 2006

Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre studyHartmut Göbel, Axel Heinze, Gerhard Reichel, et al.

Pageof 32